Effects of bead size and polymerization in PMMA bone cement on vancomycin release
- PMID: 19197114
- DOI: 10.3233/BME-2008-0554
Effects of bead size and polymerization in PMMA bone cement on vancomycin release
Abstract
Polymethylmethacrylate (PMMA) bone cement loaded with antimicrobial agents is used for the treatment and prevention of infections in orthopaedic surgery. The use of antimicrobial-loaded bone cement allows for high local doses while avoiding systemic toxicity. The release of vancomycin (VCM) from bone cement has been reported. However, the exact mechanism behind the release is unknown. We studied the influence of bead size and polymerization time on elution, and considered the release mechanism for VCM. We used CMW Endurance Bone Cement. Cements were prepared by mixing 6 g of VCM with 40 g of polymer, and then 10 g of liquid monomer was added. We kneaded and shaped the preparation into spheres containing 10.7 w/w% VCM. We measured the release of VCM from PMMA beads of three different sizes. Average weights of the beads were 0.96 g (SB) (n = 6), 2.86 g (MB) (n = 2) and 5.65 g (LB) (n = 1). Additionally, we studied beads made with different polymerization times. The polymerization time was taken as the period from the making of the beads until the start of the study, and was 15 min (B15), 20 min (B20), 60 min (B60) or 180 min (B180). The release of VCM showed a bimodal curve with a high initial release followed by a sustained release. Regarding the size of the beads, SB released 7.2%, MB released 4.3% and LB released 3.1%. Regarding polymerization time, B15 released 10.0%, B20 released 6.5%, B60 released 6.3% and B180 released 4.3%, respectively. The release of VCM from PMMA beads was influenced by bead size and polymerization time. Those beads which were smaller and had a shorter polymerization time released more VCM. Total pore volume of beads that polymerization time was 30 min after drug-release test was 1.33 times grater than that of control beads that polymerization time was one week before drug-release test. This suggested that the short polymerization time caused the beads to leak more VCM. We proposed a model with four kinds of the dissolution from bone cement. (A) Dissolution from drug particles on the cement surface. This type shows the burst effect of release curve. (B) Dissolution from micropores near the cement surface. It is responsible the grater part of the curve based on Higuchi's equation. (C) Dissolution from ink-bottle-neck-type micropores. It causes a release based on a non-Higuchi's equation. (D) No dissolution from Encapsulation micropores.It can be concluded that the release of VCM from bone cements is controlled by a combination of surface area and polymerization time. PMMA beads loaded with VCM should be used carefully in orthopaedic surgery, taking into consideration the influence of bead size and polymerization time.
Similar articles
-
Gentamicin release from two-solution and powder-liquid poly(methyl methacrylate)-based bone cements by using novel pH method.J Biomed Mater Res A. 2004 Jun 1;69(3):577-83. doi: 10.1002/jbm.a.30033. J Biomed Mater Res A. 2004. PMID: 15127405
-
Influence of lactose addition to gentamicin-loaded acrylic bone cement on the kinetics of release of the antibiotic and the cement properties.Acta Biomater. 2010 Mar;6(3):804-11. doi: 10.1016/j.actbio.2009.08.028. Epub 2009 Aug 22. Acta Biomater. 2010. PMID: 19703595
-
In vitro elution of vancomycin from calcium phosphate cement.J Arthroplasty. 2005 Dec;20(8):1055-9. doi: 10.1016/j.arth.2005.03.035. J Arthroplasty. 2005. PMID: 16376263
-
[Bone cements based on polymethylmethacrylate].Orthopade. 2003 Jan;32(1):41-50. doi: 10.1007/s00132-002-0411-0. Orthopade. 2003. PMID: 12557085 Review. German.
-
PMMA to stabilize bone and deliver antineoplastic and antiresorptive agents.Clin Orthop Relat Res. 2003 Oct;(415 Suppl):S263-75. doi: 10.1097/01.blo.0000093053.96273.ee. Clin Orthop Relat Res. 2003. PMID: 14600618 Review.
Cited by
-
Liquid dextran does not increase the elution rate of different antibiotics from bone cement.Eur J Orthop Surg Traumatol. 2015 Jan;25(1):83-9. doi: 10.1007/s00590-013-1408-6. Epub 2014 Jan 11. Eur J Orthop Surg Traumatol. 2015. PMID: 24413846
-
Novel Bone-Targeting Agent for Enhanced Delivery of Vancomycin to Bone.Antimicrob Agents Chemother. 2015 Dec 14;60(3):1865-8. doi: 10.1128/AAC.01609-15. Antimicrob Agents Chemother. 2015. PMID: 26666918 Free PMC article.
-
Injectable gellan gum-based nanoparticles-loaded system for the local delivery of vancomycin in osteomyelitis treatment.J Mater Sci Mater Med. 2016 Jan;27(1):9. doi: 10.1007/s10856-015-5604-2. Epub 2015 Nov 30. J Mater Sci Mater Med. 2016. PMID: 26621310 Free PMC article.
-
Charcot foot and ankle with osteomyelitis.Diabet Foot Ankle. 2013 Oct 1;4. doi: 10.3402/dfa.v4i0.21361. Diabet Foot Ankle. 2013. PMID: 24098835 Free PMC article. Review.
-
Pharmacokinetic Interpretation of Applying Local Drug Delivery System for the Treatment of Deep Surgical Site Infection in the Spine.Pharmaceutics. 2024 Jan 10;16(1):94. doi: 10.3390/pharmaceutics16010094. Pharmaceutics. 2024. PMID: 38258104 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Miscellaneous